Cognitive functioning in sporadic amyotrophic lateral sclerosis: A six month longitudinal study

Author(s): Robinson KM, Lacey SC, Grugan P, Glosser G, Grossman M, et al.

Abstract

Objective: To observe changes in cognition over six months in subjects with recently diagnosed sporadic amyotrophic lateral sclerosis (ALS).

Methods: The study used a between-group and within-group longitudinal design. Nineteen ALS subjects and eight matched caregivers were recruited to participate in baseline neuropsychological assessments that were repeated six months later. Between group comparisons for these variables were undertaken at baseline and six months later. Within group/across time comparisons for these variables were carried out for both groups. Individual analyses for the neuropsychological variables using z scores were done for the ALS subjects using their baseline performance as the basis for comparison with their six month performance.

Results: The between-group and within-group comparisons did not show significant differences in cognitive function over time. In individual analyses, however, seven of 19 ALS subjects (36.84%) developed abnormal neuropsychological performance over six months.

Conclusions: Early in the disease course, over one third of the ALS subjects developed cognitive deficits over six months. These findings support the hypothesis that cognitive deficits in ALS become more prominent over time.

Similar Articles

Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease

Author(s): Lattante S, Conte A, Zollino M, Luigetti M, Del Grande A, et al.

Amyotrophic Lateral Sclerosis – Frontotemporal Spectrum Disorder (ALS-FTSD): Revised diagnostic criteria

Author(s): Strong MJ, Abrahams S, Goldstein LH, Wooley S, Mclaughlin P, et al.

Genetic counselling in ALS: facts, uncertainties and clinical suggestions

Author(s): Chiò A, Battistini S, Calvo A, Caponnetto C, Conforti FL, et al.

New ALS-Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis

Author(s): Sabatelli M, Marangi G, Conte A, Tasca G, Zollino M, et al.

ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis

Author(s): Lattante S, Pomponi MG, Conte A, Marangi G, Bisogni G, et al.

Pathological laughing and crying in amyotrophic lateral sclerosis

Author(s): McCullagh S, Moore M, Gawel M, Feinstein A

The El Escorial criteria: strengths and weakessnes

Author(s): Agosta F, Al-Chalabi A, Filippi M, Hairdman O, Kaji R, et al.

Cognitive changes predict functional decline in ALS: a polupaltion-based longitudinal study

Author(s): Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, et al.

Premorbid personality characteristics of patients with ALS

Author(s): Grossman AB, Bonnie EL, Bradley WG

Emotional Adjustment in Amyotrophic Lateral Sclerosis (ALS)

Author(s): Lulè D, Paulì S, Altinas E, Singer U, Mèrk T, et al.

Prevalence of Fatigue and depression in ALS patients and change over time

Author(s): McElhiney MC, Rabkin JC, Gordon PH, Goetz R, Mitsumoto H

Deficits in emotional and social cognition in Amyotrophic Lateral Sclerosis

Author(s): Girardi A, MacPherson SE, Abrahams S

Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum

Author(s): Lillo P, Savage S, Mioshui E, Kiernan MC, Hodges JR

La diagnosi in psichiatria

Author(s): Frances A

The cognitive profiles of ALS: A systematic review and meta-analisis update

Author(s): Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand BA, et al.

Functional scales and motor assessment in Amyotrophic Lateral Sclerosis

Author(s): Benaim C, Desnuelle C, Fourniere-Mehouas M

The Amyotrophic Lateral Sclerosis Functional Rating Scale

Author(s): ALS CNTF Treatment Study (ACTS) Phase I-II Study Group

The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS)

Author(s): Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, et al.